Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SYNGR3 mRNA | CTD | PMID:24763279 | 1,2-dimethylhydrazine | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SYNGR3 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Syngr3 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of SYNGR3 mRNA] | CTD | PMID:22206623 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:15329391 | 17beta-estradiol | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SYNGR3 mRNA | CTD | PMID:19167446 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SYNGR3 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SYNGR3 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Syngr3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYNGR3 mRNA | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SYNGR3 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Syngr3 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SYNGR3 mRNA | CTD | PMID:20188158 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SYNGR3 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of SYNGR3 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SYNGR3 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of SYNGR3 mRNA | CTD | PMID:21632981 | all-trans-retinoic acid | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SYNGR3 mRNA | CTD | PMID:21934132 | aristolochic acid A | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SYNGR3 mRNA | CTD | PMID:33212167 | atrazine | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of SYNGR3 mRNA | CTD | PMID:22378314 | azoxystrobin | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | azoxystrobin results in decreased expression of SYNGR3 mRNA | CTD | PMID:33512557 | benzo[a]pyrene | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SYNGR3 mRNA | CTD | PMID:20106945 and PMID:21632981 | benzo[a]pyrene | increases methylation | ISO | SYNGR3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SYNGR3 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SYNGR3 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SYNGR3 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SYNGR3 mRNA | CTD | PMID:30816183 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SYNGR3 gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of SYNGR3 gene | CTD | PMID:31601247 | calcitriol | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SYNGR3 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SYNGR3 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SYNGR3 mRNA | CTD | PMID:25979313 | chlorpyrifos | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SYNGR3 mRNA | CTD | PMID:29156651 | coumestrol | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of SYNGR3 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SYNGR3 mRNA | CTD | PMID:27989131 | cyclosporin A | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SYNGR3 mRNA | CTD | PMID:21632981 and PMID:25562108 | dorsomorphin | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SYNGR3 mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA | CTD | PMID:19167446 | entinostat | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | entinostat results in increased expression of SYNGR3 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | Syngr3 (Mus musculus) | 6480464 | Ethanol affects the splicing of SYNGR3 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Syngr3 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of SYNGR3 mRNA] | CTD | PMID:22206623 | fulvestrant | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of SYNGR3 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SYNGR3 mRNA | CTD | PMID:33387578 | heroin | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Heroin results in decreased expression of SYNGR3 mRNA | CTD | PMID:16710320 | ivermectin | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SYNGR3 protein | CTD | PMID:32959892 | lead(0) | affects expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Lead affects the expression of SYNGR3 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of SYNGR3 mRNA | CTD | PMID:35811015 | mercury dibromide | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of SYNGR3 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNGR3 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Syngr3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SYNGR3 mRNA | CTD | PMID:17562736 | phenylmercury acetate | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of SYNGR3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNGR3 mRNA | CTD | PMID:27188386 | PhIP | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of SYNGR3 mRNA | CTD | PMID:20816883 | picoxystrobin | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of SYNGR3 mRNA | CTD | PMID:33512557 | quercetin | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of SYNGR3 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SYNGR3 mRNA | CTD | PMID:19167446 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | Silver results in decreased expression of SYNGR3 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Syngr3 (Mus musculus) | 6480464 | Silver results in decreased expression of SYNGR3 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SYNGR3 mRNA | CTD | PMID:34032870 | sodium dodecyl sulfate | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of SYNGR3 mRNA | CTD | PMID:31734321 | sulforaphane | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of SYNGR3 mRNA | CTD | PMID:31838189 | tebufenpyrad | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SYNGR3 mRNA | CTD | PMID:33512557 | testosterone | multiple interactions | ISO | SYNGR3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SYNGR3 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Testosterone results in increased expression of SYNGR3 mRNA | CTD | PMID:21592394 | thimerosal | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SYNGR3 mRNA | CTD | PMID:27188386 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SYNGR3 mRNA | CTD | PMID:33387578 | tris(2-butoxyethyl) phosphate | affects expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SYNGR3 mRNA | CTD | PMID:29024780 | valproic acid | increases methylation | ISO | SYNGR3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SYNGR3 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SYNGR3 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SYNGR3 mRNA | CTD | PMID:25979313 | vorinostat | decreases expression | ISO | SYNGR3 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SYNGR3 mRNA | CTD | PMID:27188386 | |